REDCARE PHARMACY NV (RDC.DE) Forecast, Price Target & Analyst Ratings

FRA:RDCNL0012044747

Current stock price

37.22 EUR
+0.08 (+0.22%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REDCARE PHARMACY NV (RDC.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€101.03
+ 171.43% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€101.03
Upside
+ 171.43%
From current price of €37.22 to mean target of €101.03, Based on 16 analyst forecasts
Low
€54.54
Median
€100.98
High
€157.50

Price Target Revisions

1 Month
-25.68%
3 Months
-30.65%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for RDC.DE. The average price target is 101.03 EUR. This implies a price increase of 171.43% is expected in the next year compared to the current price of 37.22.
The average price target has been revised downward by 30.65% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

RDC Current Analyst RatingRDC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

RDC Historical Analyst RatingsRDC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
RDC.DE was analyzed by 16 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about RDC.DE.
In the previous month the buy percentage consensus was at a similar level.
RDC.DE was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-26BerenbergMaintains Buy -> Buy
2025-07-17Metzler EquitiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
RDC.DE revenue by date.RDC.DE revenue by date.
1.799B
49.35%
2.371B
31.79%
2.941B
24.06%
3.529B
20.00%
4.087B
15.81%
4.834B
18.28%
5.665B
17.19%
5.903B
4.20%
6.372B
7.95%
6.725B
5.54%
EBITDA
YoY % growth
RDC.DE ebitda by date.RDC.DE ebitda by date.
49.669M
455.03%
29.778M
-40.05%
47.4M
59.18%
104.16M
119.75%
157.68M
51.38%
212.06M
34.49%
263.39M
24.21%
N/AN/AN/A
EBIT
YoY % growth
RDC.DE ebit by date.RDC.DE ebit by date.
-7.619M
85.76%
-38.439M
-404.52%
-22M
42.77%
10.46M
147.55%
49.549M
373.70%
100.23M
102.28%
229.94M
129.41%
265.93M
15.65%
N/AN/A
Operating Margin
RDC.DE operating margin by date.RDC.DE operating margin by date.
-0.42%-1.62%-0.75%0.30%1.21%2.07%4.06%4.50%N/AN/A
EPS
YoY % growth
RDC.DE eps by date.RDC.DE eps by date.
N/A
74.56%
N/A
-91.90%
-1.49
22.65%
0.14
109.46%
1.99
1,309.59%
7.61
282.87%
11.16
46.64%
N/AN/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RDC.DE Yearly Revenue VS EstimatesRDC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
RDC.DE Yearly EPS VS EstimatesRDC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
92.25%
EPS Next 5 Year
75.50%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
17.51%
Revenue Next 5 Year
14.66%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
160.07%
EBIT Next 5 Year
114.99%

REDCARE PHARMACY NV / RDC.DE Forecast FAQ

What is the average price target for REDCARE PHARMACY NV (RDC.DE) stock?

16 analysts have analysed RDC.DE and the average price target is 101.03 EUR. This implies a price increase of 171.43% is expected in the next year compared to the current price of 37.22.

Can you provide the upcoming earnings date for REDCARE PHARMACY NV?

REDCARE PHARMACY NV (RDC.DE) will report earnings on 2026-05-06.

Can you provide the expected long term growth rate for REDCARE PHARMACY NV stock?

The expected long term growth rate for REDCARE PHARMACY NV (RDC.DE) is 17.51%.